Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia. [electronic resource]
Producer: 20160803Description: 240-2 p. digitalISSN:- 1536-3678
- Antineoplastic Agents -- adverse effects
- Child
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Neoplasm Recurrence, Local -- drug therapy
- Niacinamide -- adverse effects
- Phenylurea Compounds -- adverse effects
- Posterior Leukoencephalopathy Syndrome -- chemically induced
- Salvage Therapy -- methods
- Sorafenib
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.